تداخل‌های دارویی
Bromocriptine + Dihydroergotamine intranasal
شدت: شدید
Bromocriptine and Dihydroergotamine intranasal: major interaction.
آخرین به‌روزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Intranasal dihydroergotamine is absorbed systemically and combined with bromocriptine may add to ergot-related vasoconstriction, causing hypertension, vasospasm or peripheral ischemia. The combination offers little benefit relative to its risk.
معنای این تداخل به زبان ساده
Bromocriptine and Dihydroergotamine intranasal can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
چرا رخ می‌دهد
Additive pharmacodynamic vasoconstrictive and ergot-related effects at vascular receptors.
اقدام لازم
Avoid the combination and use a non-ergot migraine therapy if bromocriptine is required. If both are used, monitor blood pressure and for signs of ischemia.
از داروساز چه بپرسید
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Bromocriptine و Dihydroergotamine intranasal، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Bromocriptine
پرسش‌های متداول
Can I take Bromocriptine with Dihydroergotamine intranasal?
MediHelp rates the interaction as major. Bromocriptine and Dihydroergotamine intranasal can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Intranasal dihydroergotamine is absorbed systemically and combined with bromocriptine may add to ergot-related vasoconstriction, causing hypertension, vasospasm or peripheral ischemia. The combination offers little benefit relative to its risk.
How serious is the interaction between Bromocriptine and Dihydroergotamine intranasal?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination and use a non-ergot migraine therapy if bromocriptine is required. If both are used, monitor blood pressure and for signs of ischemia.
What other medicines interact with Bromocriptine?
MediHelp also lists interactions of Bromocriptine with, for example, Amisulpride, Atazanavir, Cobicistat. The full list is on the Bromocriptine page.
تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.
